SCHEMBL2137404

SCHEMBL2137404

O=[N+]([O-])c1ccc(-c2ccccc2)c([N+](=O)[O-])c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.63
TDP1 Q9NUW8 2/20 0.63
POLB P06746 1/20 0.59
RAB9A P51151 1/20 0.59
PTGS2 P35354 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.52
MAPK1 P28482 2/20 0.52
HIF1A Q16665 2/20 0.52
TP53 P04637 1/20 0.52
HPGD P15428 1/20 0.52
TSHR P16473 1/20 0.52
GPR35 Q9HC97 1/20 0.52
PTPRC P08575 2/20 0.51
BCHE P06276 1/20 0.51
ACHE P22303 1/20 0.51
CES1 P23141 1/20 0.51
S100A4 P26447 1/20 0.51
CES2 O00748 1/20 0.51
TXNRD1 Q16881 1/20 0.50
TXNRD3 Q86VQ6 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL27408458 0.98 ALDH1A1 (0.61) ALDH1A1TDP1POLBRAB9APTGS2
Formaldehyde SCHEMBL29219144 0.96 ALDH1A1 (0.59) ALDH1A1TDP1POLBRAB9APTGS2
SCHEMBL11351696 0.91 ALDH1A1 (0.58) ALDH1A1TDP1POLBRAB9APTGS2
SCHEMBL9798213 0.89 PTGS2 (0.55) ALDH1A1TDP1POLBRAB9APTGS2
SCHEMBL10937400 0.87 MAPT (0.56) ALDH1A1TDP1POLBRAB9APTGS2
SCHEMBL10904251 0.85 ALDH1A1 (0.63) ALDH1A1TDP1POLBRAB9APTGS2
SCHEMBL6391559 0.85 PTGS2 (0.69) ALDH1A1TDP1POLBRAB9APTGS2
SCHEMBL28207049 0.85 PTGS2 (0.73) ALDH1A1TDP1POLBRAB9APTGS2
SCHEMBL5958796 0.84 TDP1 (0.65) ALDH1A1TDP1SMN1; SMN2MAPK1HIF1A
SCHEMBL3276362 0.83 TDP1 (0.66) ALDH1A1TDP1POLBRAB9APTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110713454-A Nitro-substituted indole compound and preparation method thereof 南京工业大学 2020-01-21 CN claimed
CN-109721497-A The new synthetic method of one kind 2,4- dinitro biphenyl 于鹏 2019-05-07 CN claimed
US-20050075324-A1 Melanin concentrating hormone antagonists THE PROCTER & GAMBLE COMPANY (US) 2005-04-07 US claimed
EP-1015402-B1 Method for producing compounds containing fluorine, in particular fluorobenzaldehydes and fluorobenzonitriles CLARIANT GMBH (DE) 2002-12-04 EP claimed
US-6166242-A Method for producing compounds containing fluorine, in particular fluorobenzaldhydes and fluorobenzonitriles AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO KG (DE) 2000-12-26 US claimed
EP-1015402-A1 METHOD FOR PRODUCING COMPOUNDS CONTAINING FLUORINE, IN PARTICULAR FLUOROBENZALDHYDES AND FLUOROBENZONITRILES Aventis Research & Technologies GmbH & Co. KG (DE) 2000-07-05 EP claimed
WO-1999011588-A1 METHOD FOR PRODUCING COMPOUNDS CONTAINING FLUORINE, IN PARTICULAR FLUOROBENZALDHYDES AND FLUOROBENZONITRILES AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) 1999-03-11 WO claimed
US-4170708-A FROM AN AROMATIC NITRO COMPOUND, AN ALCOHOL, AND CARBON MONOXIDE MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1979-10-09 US claimed
CN-110713454-B Nitro-substituted indole compound and preparation method thereof 南京工业大学 2022-12-09 CN disclosed
CN-108484372-B Method for preparing biaryl from aryl hydrazine and brominated aromatic hydrocarbon 绍兴文理学院 2021-07-02 CN disclosed
CN-110713454-A Nitro-substituted indole compound and preparation method thereof 南京工业大学 2020-01-21 CN disclosed
CN-109721497-A The new synthetic method of one kind 2,4- dinitro biphenyl 于鹏 2019-05-07 CN disclosed
CN-109721497-A The new synthetic method of one kind 2,4- dinitro biphenyl 于鹏 2019-05-07 CN disclosed
CN-109721497-A The new synthetic method of one kind 2,4- dinitro biphenyl 于鹏 2019-05-07 CN disclosed
EP-0000563-A1 Process for preparing aromatic urethanes MITSUI TOATSU CHEMICALS, Inc. (JP) 1979-02-07 EP disclosed
US-4134880-A Process for producing an aromatic urethane from nitro compounds, hydroxyl compounds and carbon monoxide using metal-Lewis acid-ammonia catalyst systems MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1979-01-16 US disclosed
US-4080365-A Process for preparing aromatic urethanes MITSUI TOATSU CHEMICALS (JA) 1978-03-21 US disclosed
US-4070391-A Process for producing isocyanate from nitro compounds and carbon monoxide using rhodium oxide catalysts ETHYL CORPORATION (US) 1978-01-24 US disclosed
US-4052420-A PROCESS FOR PRODUCING DIURETHANE FROM DINITRO COMPOUNDS, HYDROXYL COMPOUNDS AND CARBON MONOXIDE ETHYL CORPORATION (US) 1977-10-04 US disclosed
US-4052437-A PROCESS FOR PRODUCING URETHANE FROM NITRO COMPOUNDS, HYDROXYL COMPOUNDS AND CARBON MONOXIDE USING RHODIUM OXIDE CATALYSTS ETHYL CORPORATION (US) 1977-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075324-A1 Melanin concentrating hormone antagonists MCHR1, MCHR2, MC1R ALDH1A1 3383/4885TDP1 4156/4885POLB 4762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.